Clinical Research Directory
Browse clinical research sites, groups, and studies.
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Sponsor: Sahlgrenska University Hospital
Summary
Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis is good, but some patients will have recurrent or persistent disease after concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop distant metastases that can be treated with good results. The aim of this study is to identify and describe functional outcome in patients diagnosed with anal cancer. We will study patients from diagnosis, try to identify early toxicity to treatment and then identify long-term morbidity.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2021-08-01
Completion Date
2035-04-01
Last Updated
2023-12-08
Healthy Volunteers
No
Conditions
Interventions
Questionnaires
Patients will be answering questionnaires at 0, 3, 12, 36, 60 and 120 months
Locations (1)
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden